Although EGFR is the most commonly overexpressed tyrosine kinase receptor in head and neck cancer, also other receptors are overexpressed like HER2, HER3, and IL-6 receptor[20,21], which could possibly play a role in hypoxia-induced activation of AKT. The gene discussed is AKT1; the disease is head and neck cancer.